Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study

Abstract

Interest in lycopene has focused primarily on its use in the chemoprevention of prostate cancer (CaP); there are few clinical trials involving men with established disease. In addition, most data examining its mechanism of action have been obtained from experiments using immortal cell lines. We report the inhibitory effect(s) of lycopene in primary prostate epithelial cell (PEC) cultures, and the results of a pilot phase II clinical study investigating whole-tomato lycopene supplementation on the behavior of established CaP, demonstrating a significant and maintained effect on prostate-specific antigen velocity over 1 year. These data reinforce the justification for a large, randomized, placebo-controlled study.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, Anderson RN et al. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer 2003; 97: 3133–3275.

    Article  Google Scholar 

  2. Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson MA, Waisman Z et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol 2002; 168: 2505–2509.

    Article  Google Scholar 

  3. Barber NJ, Barber J . Lycopene and prostate cancer. Prostate Cancer Prostatic Dis 2002; 5: 6–12.

    Article  CAS  Google Scholar 

  4. White H . A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980; 48: 817–838.

    Article  Google Scholar 

  5. Diwardkar-Navsariwala V, Novotny JA, Gustin DM, Sosman JA, Rodvold KA, Crowell JA et al. Compartmental analysis of the dynamics of lycopene metabolism in healthy men. Presented at The 13th International Symposium on Carotenoids, Hawaii, 2002.

  6. Haenszel W, Kurihara M . Studies of Japanese migrants. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 35: 291–297.

    Google Scholar 

  7. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ et al. Cis–trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomakers Prev 1996; 5: 823–833.

    CAS  Google Scholar 

  8. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willet WC . Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995; 87: 1767–1776.

    Article  CAS  Google Scholar 

  9. Gann PH, Ma J, Giovannucci, Sacks FM, Hennekens CH, Stampfer MJ . Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999; 59: 1225–1230.

    CAS  PubMed  Google Scholar 

  10. Wu K, Erdman Jr JW, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK et al. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case–control study. Cancer Epidemiol Biomarkers Prev 2004; 13: 260–269.

    Article  CAS  Google Scholar 

  11. Zhang LX, Cooney RV, Bertram JS . Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991; 12: 2109–2114.

    Article  CAS  Google Scholar 

  12. Aust O, Ale-Aghe N, Zhang L, Wollersen H, Sies H, Stahl W . Lycopene oxidation product enhances gap junctional communication. Food Chem Toxicol 2003; 41: 1399–1407.

    Article  CAS  Google Scholar 

  13. Bankson DD, Countryman CJ, Collins SJ . Potentiation of the retinoic acid-induced differentiation of HL-60 cells by lycopene. Am J Clin Nutr 2001; 53 (Suppl): 13.

    Google Scholar 

  14. Obermuller-Jevic UC, Olano-Martin E, Corbacho A, Eiserich JP, van der Vliet A, Valacchi G et al. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 2003; 133: 3356–3360.

    Article  Google Scholar 

  15. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E et al. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 2001; 87: 814–820.

    Article  CAS  Google Scholar 

  16. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P et al. Plasma insulin like growth factor 1 and prostate cancer risk; a prospective study. Science 1998; 279: 5635–5666.

    Article  Google Scholar 

  17. Herzog A, Siler U, Spitzer V, Seifert N, Denelavas A, Huntziker PB . Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate. FASEB J 2005; 19: 272–274.

    Article  CAS  Google Scholar 

  18. Siler U, Barella L, Spitzer V, Schnorr J, Lein M, Goralczyk R et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J 2004; 18: 1019–1021.

    Article  CAS  Google Scholar 

  19. Pastori M, Pfander H, Boscoboinik D, Azzi A . Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate cancer cells. Biochem Biophys Res Commun 1998; 250: 582–585.

    Article  CAS  Google Scholar 

  20. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A . Carotenoids affect proliferation of human prostate cancer cells. J Nutr 2001; 131: 3303–3306.

    Article  CAS  Google Scholar 

  21. Kim L, Rao AV, Rao LG . Effect of lycopene on prostate LNCaP cancer cells in culture. J Med Food 2002; 5: 181–187.

    Article  CAS  Google Scholar 

  22. Forbes K, Gillette K, Sehgal I . Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line. A brief communication. Exp Biol Med (Maywood) 2003; 228: 967–971.

    Article  CAS  Google Scholar 

  23. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman Jr JW, Clinton SK . Prostate carcinogenesis in N-methyl-N-nitrosurea (NMU)-testosterone treated rats fed tomato powder, lycopene or energy restricted diet. J Natl Cancer Inst 2003; 95: 1578–1586.

    Article  CAS  Google Scholar 

  24. Richards LR, Benghuzzi H, Tucci M, Hughs J . The synergistic effect of conventional and sustained delivery of antioxidants on LNCaP prostate cancer cell line. Biomed Sci Instrum 2003; 39: 402–407.

    CAS  PubMed  Google Scholar 

  25. Campbell JK, Canene-Adams K, Lindshield BL, Boileau TW, Clinton SK, Erdman Jr JW . Tomato phytochemicals and prostate cancer risk. J Nutr 2004; 134 (Suppl): 3486S–3492S.

    Article  CAS  Google Scholar 

  26. Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollack MN, Khachik F et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2001; 10: 861–868.

    CAS  PubMed  Google Scholar 

  27. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen R et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole food intervention. J Natl Cancer Inst 2001; 93: 1872–1879.

    Article  CAS  Google Scholar 

  28. Kim HS, Bowen P, Chen L, Duncan C, Ghosh L, Sharifi R et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer 2003; 47: 40–47.

    Article  CAS  Google Scholar 

  29. Ansari MS, Gupta NP . A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int 2003; 92: 375–378.

    Article  CAS  Google Scholar 

  30. Kranse R, Dagnelie PC, van Kemenade MC, de Jong FH, Blom JH, Tijburg LB et al. Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo controlled study. Int J Cancer 2005; 113: 835–840.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N J Barber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barber, N., Zhang, X., Zhu, G. et al. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study. Prostate Cancer Prostatic Dis 9, 407–413 (2006). https://doi.org/10.1038/sj.pcan.4500895

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500895

Keywords

This article is cited by

Search

Quick links